Welcome : Guest

Stellar Biotechnologies, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Stellar Biotechnologies, Inc., which is principally a Biotechnology Company. Illustrated with 90 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-66338
Price: $3500
Company Type: Public
Pages: 93
Date: March 2017
Market Data Tables: 90

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1:Stellar Biotechnologies, Inc.’s Sales by Geographic Region Worldwide (2015-2016) in Percentage for Europe, Asia, and U.S......3
Table 2:Stellar Biotechnologies, Inc.’s Sales by Product Segment Worldwide (2015-2016) in Percentage for Product Sales (Stellar KLH™ Products), and Contract Services Revenue......4
Table 3: Stellar Biotechnologies, Inc.'s Revenues by Category (2015) in Percentage for Contract Services Revenue, and Product Sales (STellar KLH Products)......5
Biotechnology......7
Table 4: Biotechnology Market by Category in China (2015) - Percentage Share Breakdown by Value for Biopharmaceutical and Chemical......7
Table 5: Biotechnology Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biopharmaceutical and Chemical......8
Biotesting (Outsourced)......9
Table 6: Outsourced Biotesting Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Environment, Pharma and Others......9
Biotechnology Drugs......10
Table 7: Biotechnology Drugs by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Cell Therapy, Gene Therapy, Monoclonal Antibodies (MAB), Recombinant Hormones and Proteins, Vaccines, and Others......10
Immunotherapy......11
Table 8: No. of Patients for Immunotherapy by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Europe, North America, and Others......11
Table 9: Immunotherapy Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union, United States and Rest of the World......12
Table 10: Immunotherapy Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Subcutaneous, and Sublingual......13
Table 11: No. of Patients for Immunotherapy by Age Group in the US (2015) - Percentage Market Share Breakdown by Value for 0-4 Patient Pool, 10 - 14 Patient Pool, 15 - 19 Patient Pool, 5-9 Patient Pool, Adult Patient Pool (over 65), and Adult Patient Pool (under 65)......14
Table 12: Allergy Immunotherapy Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, France, Germany, Italy, Spain and Others......15
Table 13: Grass Allergy Immunotherapy Treatment by Segment in Germany (2015) - Percentage Breakdown by No. of Patients for Subcutaneous, Sublingual, and Tablet......16
Table 14: Grass Allergy Immunotherapy Treatment by Type in Germany (2015) - Percentage Breakdown by No. of New Patients for Subcutaneous, and Sublingual......17
Cancer Drugs......18
Table 15: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......18
Table 16: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......19
Cancer Market......20
Table 17: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......20
Table 18: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......21
Table 19: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......22
Table 20: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......23
Table 21: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......24
Table 22: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......25
Table 23: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......26
Table 24: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......27
Cancer Patients......28
Table 25: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......28
Table 26: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......29
Table 27: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......30
Table 28: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......31
Table 29: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......32
Table 30: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......33
Table 31: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......34
Table 32: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......35
Table 33: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......36
Table 34: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......37
Table 35: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......38
Table 36: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......39
Table 37: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......40
Table 38: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......41
Table 39: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......42
Table 40: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......43
Table 41: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......44
Table 42: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......45
Table 43: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......46
Table 44: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......47
Table 45: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......48
Cervical Cancer......49
Table 46: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......49
Table 47: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......50
Hematological Cancer......51
Table 48: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......51
Skin Cancer......52
Table 49: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......52
Cancer-Associated Mucositis......53
Table 50: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......53
Chronic Myelogenous Leukemia (CML)......54
Table 51: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......54
Multiple Myeloma......55
Table 52: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......55
Table 53: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......56
Inflammatory Bowel Disease (IBD) Drugs......57
Table 54: Inflammatory Bowel Disease (IBD) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Anti-Inflammatory, Biologics, and Immunomodulatory......57
Vaccines......58
Table 55: Vaccines Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Adult Prophylactic Vaccines (USD 8.5bn), Pediatric Vaccines (USD 16.7bn) and Others......58
Diagnostic Testing......59
Table 56: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hospitals, Independent Labs*, Physician Office Labs and Others......59
Table 57: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Volume Sales for Hospitals, Independent Labs*, Physician Office Labs and Others......60
Table 58: Diagnostics Tests Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......61
Table 59: Diagnostics Tests Market by Type in the US (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......62
Table 60: Diagnostic Test Sales by Category in the US (2015) - Percentage Market Share Breakdown by No. of Solid Tumour Patients for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......63
Table 61: Diagnostic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Ambulatory Physician Services, and Hospital Services......64
Table 62: Diagnostic Testing Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Hospital Outreach, Independent Labs, Inpatient, Outpatient, POLs, and Others......65
Table 63: Diagnostic Testing Sales by Category in the US (2015) - Percentage Share Breakdown by Value for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......66
Biotechnology......67
Table 64: Market Shares of Leading Biotechnology Companies Worldwide (2015) - Percentage Breakdown by Value for Amgen, Inc., Merck KGaA, Monsanto Company, Roche Holding AG, Syngenta AG, and Others......67
Table 65: Market Shares of Leading Agricultural Biotechnology Companies Worldwide (2015) - Percentage Breakdown by Research and Development (R&D) Expenditure for Bayer CropScience AG, Dow AgroSciences LLC, DuPont Pioneer, Monsanto Co., Inc., Syngenta AG and Others......68
Table 66: Market Shares of Leading Biotechnology Companies in China (2015) - Percentage Share Breakdown by Value for F. Hoffmann-La Roche Ltd., MERCK SERONO CO., LTD., Novo Nordisk A/S, Qilu Pharmaceutical Co., Ltd. and Others......69
Outsourced Biotesting......70
Table 67: Market Shares of Leading Outsourced Biotesting Companies Worldwide (2015) - Percentage Share Breakdown by Value for Eurofins Scientific, SGS S.A. and Others......70
Colony-Stimulating Factor (GCSF)......71
Table 68: Market Shares of Leading Granulocyte Colony-Stimulating Factor (GCSF) Companies in China (2014) - Percentage Share Breakdown by Value for Amoytop Biotech Co., Ltd., Harbin Pharmaceutical Group Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Qilu pharmaceutical Co., Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd., and Others......71
Cancer Drugs......72
Table 69: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......72
Table 70: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......73
Table 71: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......74
Table 72: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......75
Table 73: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......76
Breast Cancer Drugs......77
Table 74: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......77
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......78
Table 75: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......78
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......79
Table 76: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Other......79
Table 77: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......80
Vaccines......81
Table 78: Market Shares of Leading Vaccine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc (GSK), Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......81
Diphtheria and Tetanus Vaccines......82
Table 79: Market Shares of Leading Diphtheria and Tetanus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Infanrix), and Others......82
Hepatitis A Vaccines......83
Table 80: Market Shares of Leading Hepatitis A Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Havrix), and Others......83
Hepatitis B (Recombinant) Vaccines......84
Table 81: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......84
Hepatitis A and Typhoid Polysaccharide Vaccines......85
Table 82: Market Shares of Leading Hepatitis A and Typhoid Polysaccharide Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hepatyrix), and Others......85
Human Papillomavirus Vaccines......86
Table 83: Market Shares of Leading Human Papillomavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Cervarix), and Others......86
Human Rotavirus Vaccines......87
Table 84: Market Shares of Leading Human Rotavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Rotarix), and Others......87
Influenza Vaccines......88
Table 85: Market Shares of Leading Influenza Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Fluarix), and Others......88
Measles, Mumps and Rubella Vaccines......89
Table 86: Market Shares of Leading Measles, Mumps and Rubella Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Priorix), and Others......89
Tetanus Toxoid, reduced Diphthera Vaccines......90
Table 87: Market Shares of Leading Tetanus Toxoid, reduced Diphthera Vaccine Manufacturers in India (2014) - Percentage Breakdown by Value Sales for GlaxoSmithKline Plc (Boostrix), and Others......90
Typhoid Vaccines......91
Table 88: Market Shares of Leading Typhoid Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Typherix), and Others......91
Varilrix Vaccines......92
Table 89: Market Shares of Leading Varilrix Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Varilrix), and Others......92
Diagnostic Testing......93
Table 90: Market Shares of Leading Diagnostic Testing Companies in the US (2015) - Percentage Share Breakdown by Value for Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated and Others......93